论文部分内容阅读
匹莫苯(pimobendan,1)是目前国外正在开发的心肌兴奋药对中、轻度充血性心力衰竭的临床疗效优于卡托普利(巯甲丙脯酸)。其中间体3-(4-氯苯甲酰)丁酸(2)的
Pimobendan (pimobendan, 1) is the current clinical development of cardiac stimulant in the treatment of mild congestive heart failure is superior to captopril (captopril). Its intermediate 3- (4-chlorobenzoyl) butanoic acid (2)